We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
S&P Futures
5,175.00 +7.50 (+0.15%) Dow Futures
38,287.00 +49.00 (+0.13%) Nasdaq Futures
18,209.25 +30.00 (+0.17%) Russell 2000 Futures
2,028.10 +8.30 (+0.41%) Crude Oil
85.41 -0.25 (-0.29%) Gold
2,371.00 -3.10 (-0.13%)
West Pharmaceutical Services, Inc. (WST)
After hours:
Chart Events
Performance Outlook
| Previous Close | 387.58 |
| Open | 384.00 |
| Bid | 375.93 x 800 |
| Ask | 382.99 x 800 |
| Day's Range | 379.73 - 384.16 |
| 52 Week Range | 310.42 - 415.73 |
| Volume | |
| Avg. Volume | 526,961 |
| Market Cap | 27.818B |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | 48.28 |
| EPS (TTM) | 7.87 |
| Earnings Date | Apr 25, 2024 |
| Forward Dividend & Yield | 0.80 (0.21%) |
| Ex-Dividend Date | Apr 23, 2024 |
| 1y Target Est | 400.43 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for WST
Related Research
- West Pharmaceutical Services, IWST: Raising target price to $412.00WEST PHARMACEUTICAL SERVICES has an Investment Rating of HOLD; a target price of $412.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.RatingFair ValueEconomic Moat5 days agoArgus Research
PR NewswireWest to Host First-Quarter 2024 Conference Call
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter financial results before the market opens on Thursday, April 25, 2024, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.
Insider MonkeyWhat Makes West Pharmaceutical Services (WST) an Attractive Bet?
ClearBridge Investments, an investment management firm, released its fourth-quarter 2023 “Mid Cap Growth Strategy” investor letter, a copy of which can be downloaded here. The strategy outperformed its benchmark Russell Midcap Growth Index in the quarter. The strategy gained nine of the 11 sectors it was invested in during the quarter on an absolute basis. Overall […]
ZacksMerit Medical (MMSI) Down 0.6% Since Last Earnings Report: Can It Rebound?
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksWhy Is Henry Schein (HSIC) Down 1.8% Since Last Earnings Report?
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
ZacksReasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
ZacksStrength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
West Pharmaceutical (WST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
GuruFocus.comInsider Sell: VP, Chief Accounting Officer Chad Winters Sells Shares of West Pharmaceutical ...
West Pharmaceutical Services Inc (NYSE:WST), a global leader in the design and production of containment and delivery systems for injectable drugs and healthcare products, has reported an insider sell according to a recent SEC filing.
Simply Wall St.Is West Pharmaceutical Services, Inc. (NYSE:WST) Expensive For A Reason? A Look At Its Intrinsic Value
Key Insights West Pharmaceutical Services' estimated fair value is US$295 based on 2 Stage Free Cash Flow to Equity...
GuruFocus.comWest Pharmaceutical Services Inc President and CEO Eric Green Sells Company Shares
Eric Green, President, CEO, and Board Chair of West Pharmaceutical Services Inc (NYSE:WST), has sold 64,132 shares of the company on February 27, 2024, according to a recent SEC Filing.
- PR Newswire
West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.
Morningstar Rating
Rating
Fair Value
Economic Moat
People Also Watch
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| TFX Teleflex Incorporated | |||
| STE STERIS plc | |||
| MTD Mettler-Toledo International Inc. | |||
| ROP Roper Technologies, Inc. | |||
| COO The Cooper Companies, Inc. |
Similar to WST
| Symbol | Last Price | Change | % Change |
|---|---|---|---|
| TFX Teleflex Incorporated | |||
| COO The Cooper Companies, Inc. | |||
| RMD ResMed Inc. | |||
| BDX Becton, Dickinson and Company | |||
| STVN Stevanato Group S.p.A. |
Analyst Price Targets (7)
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 2/16/2024 | |
| Maintains | Keybanc: Overweight to Overweight | 2/13/2024 | |
| Upgrade | Jefferies: Hold to Buy | 2/7/2024 | |
| Maintains | Stephens & Co.: Overweight to Overweight | 10/27/2023 | |
| Maintains | Keybanc: Overweight to Overweight | 8/30/2023 | |
| Maintains | Keybanc: Overweight to Overweight | 8/21/2023 |
Company Profile
530 Herman O. West Drive
Exton, PA 19341-1147
United States
610 594 2900
https://www.westpharma.com
Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 10,600
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
